about
The evolutionary rate of antibacterial drug targetsA Specialized Histone H1 Variant Is Required for Adaptive Responses to Complex Abiotic Stress and Related DNA Methylation in ArabidopsisOpen Drug Discovery Toolkit (ODDT): a new open-source player in the drug discovery fieldPlant MicroRNAs-Novel Players in Natural Medicine?Why similar protein sequences encode similar three-dimensional structures?Methods of molecular modelling of protein-protein interactions.Theoretical model explaining the relationship between the molecular mass and the activation energy of the enzyme revealed by a large-scale analysis of bioinformatics data.FEDMA--a simple algorithm for theoretical modeling of linear metabolic pathways: from fuzzy data sets to prediction and experiment.A comprehensive, quantitative, and genome-wide model of translationIn silico identification of plant miRNAs in mammalian breast milk exosomes--a small step forward?The clinical response to vemurafenib in a patient with a rare BRAFV600DK601del mutation-positive melanoma.A kinetic model of the evolution of a protein interaction networkDiscovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain.Transimulation - protein biosynthesis web serviceHigh-throughput sequencing identification of novel and conserved miRNAs in the Brassica oleracea leavesCo-regulation of translation in protein complexes.Tools4miRs - one place to gather all the tools for miRNA analysisDominance from the perspective of gene-gene and gene-chemical interactionsThe High Throughput Sequence Annotation Service (HT-SAS) - the shortcut from sequence to true Medline words.Three-dimensional model of the potyviral genome-linked protein.Molecular dynamics simulation of the hydration shell of a B-DNA decamer reveals two main types of minor-groove hydration depending on groove widthMolecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.DeCAF-Discrimination, Comparison, Alignment Tool for 2D PHarmacophores.Structural models of CFTR-AMPK and CFTR-PKA interactions: R-domain flexibility is a key factor in CFTR regulation.Electrostatic potential of B-DNA: effect of interionic correlations.Theoretical model of reticulocyte to erythrocyte shape transformation.The quantum casimir effect may be a universal force organizing the bilayer structure of the cell membrane.Influence of macromolecular crowding on protein-protein association rates--a Brownian dynamics study.Residue solvent accessibilities in the unfolded polypeptide chain.Mapping Protein-Protein Interactions of the Resistance-Related Bacterial Zeta Toxin-Epsilon Antitoxin Complex (ε₂ζ₂) with High Affinity Peptide Ligands Using Fluorescence Polarization.Hypophosphatemia and sudden infant death syndrome (SIDS)--is ATP the link?DiSCuS: an open platform for (not only) virtual screening results management.Simulations of nucleation and early growth stages of protein crystals.Double selective synthetic approach to the N-functionalized 1,4,7-triazacyclononane derivatives: chelating compounds for controllable protein orientation.Proteins contribute insignificantly to the intrinsic buffering capacity of yeast cytoplasm.Establishment and functional validation of a structural homology model for human DNA methyltransferase 1.Biochemical kinetics in changing volumes.Discovery of two novel, small-molecule inhibitors of DNA methylation.A TIP on malaria (genomics).Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis.
P50
Q21093648-072E348B-0029-48C5-AB8D-69D9B720E84CQ27320728-D35E7618-DB07-47F0-B6AC-E0295FD054CBQ27902292-1313D0D8-3209-476D-8B1B-903E2F402E15Q28066239-EB476E18-67E7-4FC6-9407-40BBB61512F8Q29041516-C652BB8A-D51F-4F58-B5CB-D1DE511450A8Q30404301-630FB99C-F1C9-41FD-A09B-F94DD30BCD40Q30649403-72A2E635-EFE3-4212-BCA0-9CC92F3F8EB7Q30987050-C0E3DA93-71F9-4768-84B4-0986CA9F2F34Q33649778-C76573EE-7D1F-4C80-A3D5-6F08E644DBB6Q33763532-B19939E5-A878-4DDD-8932-C55F1BD98915Q34316552-BA085AFB-FFB9-46D7-80B3-DF4F652D893BQ34622500-090A64BE-F32F-4E2E-9400-9C406EB3BB80Q34975364-620B2DA5-68DE-4AFC-8172-D9E6F75166E8Q34989523-55680F27-7498-413D-B368-B81CF86719BCQ35045588-9DEF6B52-F7B5-4A44-8F79-9FC1101E5C8BQ35537905-20E66683-56D7-4D2D-BD02-DBC061EF86F6Q36011077-BC87C316-1BD8-4E0C-964F-75449D3B0771Q36564341-6E4F903E-9912-44F5-81B5-7CE1C0840B07Q37223546-E1606EFD-B2CD-4B34-874E-600ECE3E4C6BQ37227373-E1758AE0-0EDA-4EB6-AEDE-0C58E4E071FEQ37377585-61A06833-537A-4F32-99CB-2ED70D52144CQ38204828-52443091-0977-4BB9-9B9D-DC291B1CA198Q38430057-E67E09BA-2EDC-4041-8CE2-5C5515EFB241Q40098219-43D149CF-87A1-49CE-8EDF-B5518152E3E2Q40133012-DA1EDBFE-F0EB-4468-9D56-1E61B1AF46F3Q40302540-27E26497-7485-4C5C-8B67-DC5F1C0EB055Q40710181-0C5CAF35-3B84-4043-9171-93EB6A0D6D0AQ41668452-37B479F3-F5A8-41C1-BDD6-D8F139523FF3Q41875611-937310B4-1919-422E-9325-90B6BE056E7FQ42398396-BAB7E800-686C-4F1C-83A6-854753AA578DQ42574025-79254D97-7EF7-4327-A46B-412E301EFC8CQ42634604-F7C12A1D-F5C6-4590-BC9E-2A2FD034B76DQ42928790-4471EED1-36FE-47C2-910D-6B89A77E8B97Q43149717-A398E9E9-126C-4D97-AA50-9D784BA465ECQ44097641-2D2C96EB-D457-44ED-A2E1-441A155BA34BQ44476768-37F34DE8-86A9-487E-A65F-90F033801E97Q44849887-92DD755F-55DE-4294-9AB5-CC79EE28A4A0Q46899041-F4A9420F-98BA-4ABF-B368-F272E4D49737Q47931571-B4E91994-5665-4CFB-B86F-8A600C8FB50CQ48549396-B4066C14-9F34-45B9-9AC5-41F308ABE354
P50
name
Piotr Zielenkiewicz
@ast
Piotr Zielenkiewicz
@ca
Piotr Zielenkiewicz
@cs
Piotr Zielenkiewicz
@en
Piotr Zielenkiewicz
@es
Piotr Zielenkiewicz
@ga
Piotr Zielenkiewicz
@gl
Piotr Zielenkiewicz
@hr
Piotr Zielenkiewicz
@hsb
Piotr Zielenkiewicz
@it
type
label
Piotr Zielenkiewicz
@ast
Piotr Zielenkiewicz
@ca
Piotr Zielenkiewicz
@cs
Piotr Zielenkiewicz
@en
Piotr Zielenkiewicz
@es
Piotr Zielenkiewicz
@ga
Piotr Zielenkiewicz
@gl
Piotr Zielenkiewicz
@hr
Piotr Zielenkiewicz
@hsb
Piotr Zielenkiewicz
@it
prefLabel
Piotr Zielenkiewicz
@ast
Piotr Zielenkiewicz
@ca
Piotr Zielenkiewicz
@cs
Piotr Zielenkiewicz
@en
Piotr Zielenkiewicz
@es
Piotr Zielenkiewicz
@ga
Piotr Zielenkiewicz
@gl
Piotr Zielenkiewicz
@hr
Piotr Zielenkiewicz
@hsb
Piotr Zielenkiewicz
@it
P1412
P1559
Piotr Zielenkiewicz
@pl
P21
P214
81152682492723310028
P27
P31
P3124
P734
P735
P7859
viaf-81152682492723310028